Jump to content

20250177374. Bcl-xl Inhibitory Compounds Having (AbbVie .)

From WikiPatents

BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same

Abstract: the present disclosure concerns bcl-xl inhibitors having low cell permeability, antibody drug conjugates (adcs) comprising the inhibitors, synthons useful for synthesizing the adcs, compositions comprising the inhibitors or adcs, and various methods of using the inhibitors and adcs.

Inventor(s): Scott L. Ackler, Nathan B. Bennett, Erwin R. Boghaert, Steve C. Cullen, George Doherty, Robin R. Frey, Anthony R. Haight, Andrew S. Judd, Aaron R. Kunzer, Violeta L. Marin, Xiaoqiang Shen, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Xilu Wang, Dennie S. Welch, Michael D. Wendt

CPC Classification: A61K31/4709 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250177374


Cookies help us deliver our services. By using our services, you agree to our use of cookies.